SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-021757
Filing Date
2023-05-12
Accepted
2023-05-12 16:06:54
Documents
5
Effectiveness Date
2023-05-12

Document Format Files

Seq Description Document Type Size
1 S-8 clsd_s-8_12may2023.htm S-8 156615
2 EX-5.1 clsd-ex5_1.htm EX-5.1 17177
3 EX-23.1 clsd-ex23_1.htm EX-23.1 4072
4 EX-FILING FEES clsd-exfiling_fees.htm EX-FILING FEES 49371
5 GRAPHIC img3420020_0.jpg GRAPHIC 29364
  Complete submission text file 0000950170-23-021757.txt   268830
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-271877 | Film No.: 23915655
SIC: 2834 Pharmaceutical Preparations